Latest News
Treatment of benign prostatic hyperplasia with drugs may be risky a new article says
Many men over the age of 50 will have BPH and the risk of developing this chronic disease increases as men get older. Consequently, up to 90 per cent of men over 80 years old have prostate cancer. However, an enlarged prostate or benign prostatic hyperplasia is a non-cancerous condition, so men should use safe treatment for treatment.
Therefore, research looking at the side effects of BPH medications is common. The article “Use of 5α-inhibitors for benign prostatic enlargement and the risk of high-quality prostate cancer” was investigated 963 patients with BPH who received 5-inhibitors (5-ARI). The results indicated an increased risk of a high degree and a lower risk of developing low-grade prostate cancer associated with the use of 5-ARI.
Therefore, the conclusion of this article was that patients treated with reduced 5α enzyme inhibitors should be aware of an increased risk of high-quality prostate cancer. This fact should be taken lightly, in that the proteinase 5-line 5NA inhibitors of BPH, such as finasteride (Proscar), dutasteride (Avodart), are prescribed as separate drug treatment or as a combination therapy with alpha-blockers.
Benign prostatic hyperplasia cause and possible therapy
The cause of an enlarged prostate is hidden inside the prostate gland. There is a theory that low levels of testosterone in elderly men cause the growth of the prostate gland. Decreased testosterone level as a cause of benign prostate hormone in the blood is doubtful because neutered children do not develop benign prostatitis as they get older.
Benign prostatic hyperplasia is caused by the pathological activity of the blood vessels within the prostate gland, which develops constantly at a concentration of hypothermia. Therefore, the only way to treat this problem is to improve the blood circulation inside the prostate by eliminating hypothermia that stops the enlarged prostate. By enabling heat therapy, Dr Allen diffuses the natural energy of the prostate, improving blood circulation in it. Thus, the treatment treats the cause of BPH.
Benign prostatic hyperplasia cause and possible therapy
According to the FDA Dr Allen system, it is a first-class medical device (generic controls). The device was registered with the Medical Care Agency as of 2010. Therefore, the reporting of a required body is not required. This means that every man with chronic pelvic pain syndrome can use it day and night without worry because it is safe. Heat therapy with Dr Allen device is patented by USPTO.
Fine Treatment is a healthcare company, manufacturer and distributor of Wearable Dr Allen therapy devices. Fine Treatment is a resource registered with the UK Department of International Trade (DIT) for international buyers. The price of the machine with guaranteed delivery is less than $ 200 worldwide.
The prostate therapy device has been successfully used by thousands of men with chronic prostatitis and BPH in more than 100 countries. Clinical study on thermoregulation has confirmed its effectiveness for men with chronic pelvic pain syndrome, and several scientific articles have been published, https://finetreatment.com/thermobalancing-therapy-medical-scientific-data/ and therefore, thermal thermotherapy treats the enlarged prostate effectively without complications.
Kenneth is a proud native of sydney, born and raised there. However, he pursued his education abroad and studied in Australia. Kenneth has worked as a journalist for almost a decade, making valuable contributions to prominent publications such as Yahoo News and The Verge. Currently, he serves as a journalist for The Hear Up, where he focuses on covering climate and science news. You can reach Kenneth at [email protected].
